Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers.
BIOTRANSFORM
A Blinded Placebo-controlled Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers. Relevance in European Population
2 other identifiers
interventional
60
1 country
1
Brief Summary
Numerous plant-based foods contain bioactive compounds, in particular polyphenols, which have antioxidant, anti-inflammatory, and metabolic regulatory effects. These so-called food bioactives (FB) are converted in the human organism, in particular by the gut microbiota and microsomal (liver/intestinal) metabolism, into numerous metabolites, which often represent the actual biologically active molecules. As part of the European HORIZON-MSCA Doctoral Network "BioTransform," two such food models are being studied as examples: 1. Olive products (Olea europaea L.) - representative of the Mediterranean diet, rich in secoiridoids and phenylethanols (especially hydroxytyrosol and tyrosol). 2. Bilberry /blueberry (Vaccinium myrtillus L.) - representative of the Central European diet, rich in anthocyanosides. Two parallel human intervention studies will be conducted, one in Graz (WP1, DC5) and one in Athens (WP1, DC3). These pilot studies will generate biological samples (blood, urine, stool) and investigate the extent to which taking these standardized dietary supplements influences glucose metabolism and markers of oxidative stress and low-grade inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2029
June 22, 2026
March 1, 2026
3 years
June 9, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in inflammatory and oxidative stress markers
The changes in the inflammatory and oxidative stress markers will be assessed through blood samples and the biomarkers: hsCRP, IL-6, TNF-a, total antioxidant capacity, ratio glutathione/ oxidiced glutathion
14 weeks
Secondary Outcomes (5)
Lipid profile
14 weeks
Inflammatory profile
14 weeks
Anthropometric profile
14 weeks
Metabolic profile
14 weeks
Microbiome profile
14 weeks
Study Arms (2)
INTERVENTION WITH OLIVE OIL EXTRACTS
EXPERIMENTALGroup of 20 people will receive olive oil extract supplements and after the washout period will receive placebo.
INTERVENTION WITH BILBERRY
EXPERIMENTALGroup of 20 participants will receive bilberry extract supplements and after the washout period a placebo phase.
Interventions
Through this pilot clinical study, the possible change of inflammatory and oxidative stress biomarkers in prediabetic, overweigh/ obese people will be observed. Blood, urine and stool samples will be collected, while weight mangment will also be controlled.
Eligibility Criteria
You may qualify if:
- years old,
- BMI\> 25 kg/m2
- prediabetic stage
- hsCRP\> 2mg/ L
- HbA1c 5,7-6,4%
- Impaired fasting glucose (IFG)
- Caucasian
You may not qualify if:
- No signed informed consent
- Supplementation or probiotic usage in the past 8 weeks
- Chronic gastrointestinal, inflammatory or metabolic diseases
- Alcohol misuse
- Pregnancy or breastfeeding
- Acute infection during the past month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laiko Hospital
Athens, 11527, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
June 9, 2026
First Posted
June 22, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
October 31, 2029
Last Updated
June 22, 2026
Record last verified: 2026-03